Reply to Radiation therapy does not increase survival in addition to standard androgen deprivation therapy for metastatic prostate cancer: An old, faded picture?

Marc Dall'Era; Mary J. Lo; Jaclyn Y. Chen; Rosemary D Cress; Ann S. Hamilton

doi:10.1002/cncr.31625

Reply to Radiation therapy does not increase survival in addition to standard androgen deprivation therapy for metastatic prostate cancer: An old, faded picture?

Marc Dall'Era, Mary J. Lo, Jaclyn Y. Chen, Rosemary D Cress, Ann S. Hamilton

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Journal	Cancer
DOIs	https://doi.org/10.1002/cncr.31625
State	Accepted/In press - Jan 1 2018

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1002/cncr.31625

Cite this

@article{a29d53e5771a435185c49a0de40138e2,

title = "Reply to Radiation therapy does not increase survival in addition to standard androgen deprivation therapy for metastatic prostate cancer: An old, faded picture?",

author = "Marc Dall'Era and Lo, {Mary J.} and Chen, {Jaclyn Y.} and Cress, {Rosemary D} and Hamilton, {Ann S.}",

year = "2018",

month = jan,

day = "1",

doi = "10.1002/cncr.31625",

language = "English (US)",

journal = "Cancer",

issn = "0008-543X",

publisher = "John Wiley and Sons Inc.",

}

TY - JOUR

T1 - Reply to Radiation therapy does not increase survival in addition to standard androgen deprivation therapy for metastatic prostate cancer

T2 - An old, faded picture?

AU - Dall'Era, Marc

AU - Lo, Mary J.

AU - Chen, Jaclyn Y.

AU - Cress, Rosemary D

AU - Hamilton, Ann S.

PY - 2018/1/1

Y1 - 2018/1/1

UR - http://www.scopus.com/inward/record.url?scp=85050462726&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85050462726&partnerID=8YFLogxK

U2 - 10.1002/cncr.31625

DO - 10.1002/cncr.31625

M3 - Article

C2 - 29975411

AN - SCOPUS:85050462726

JO - Cancer

JF - Cancer

SN - 0008-543X

ER -

Reply to Radiation therapy does not increase survival in addition to standard androgen deprivation therapy for metastatic prostate cancer: An old, faded picture?

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this